Brokerages Expect Sabra Health Care REIT Inc (SBRA) Will Announce Quarterly Sales of $162.64 Million

Equities analysts expect that Sabra Health Care REIT Inc (NASDAQ:SBRA) will announce $162.64 million in sales for the current fiscal quarter, according to Zacks. Four analysts have issued estimates for Sabra Health Care REIT’s earnings, with the highest sales estimate coming in at $163.41 million and the lowest estimate coming in at $161.92 million. Sabra Health Care REIT posted sales of $111.79 million in the same quarter last year, which would indicate a positive year-over-year growth rate of 45.5%. The firm is scheduled to issue its next quarterly earnings report on Wednesday, November 7th.

According to Zacks, analysts expect that Sabra Health Care REIT will report full-year sales of $649.57 million for the current fiscal year, with estimates ranging from $639.46 million to $659.07 million. For the next fiscal year, analysts anticipate that the business will report sales of $658.59 million per share, with estimates ranging from $645.70 million to $667.97 million. Zacks Investment Research’s sales calculations are an average based on a survey of research firms that cover Sabra Health Care REIT.

Sabra Health Care REIT (NASDAQ:SBRA) last issued its quarterly earnings results on Wednesday, August 8th. The real estate investment trust reported $1.08 EPS for the quarter, beating analysts’ consensus estimates of $0.33 by $0.75. Sabra Health Care REIT had a net margin of 62.60% and a return on equity of 11.21%. The business had revenue of $166.31 million for the quarter, compared to analysts’ expectations of $166.62 million.

SBRA has been the topic of a number of recent research reports. ValuEngine upgraded shares of Sabra Health Care REIT from a “strong sell” rating to a “sell” rating in a research report on Monday, May 28th. Raymond James upgraded shares of Sabra Health Care REIT from a “market perform” rating to an “outperform” rating in a research report on Monday, May 21st. Zacks Investment Research cut shares of Sabra Health Care REIT from a “buy” rating to a “hold” rating in a research report on Thursday, August 2nd. Jefferies Financial Group reiterated a “$21.91” rating and set a $22.00 price target on shares of Sabra Health Care REIT in a research report on Wednesday, July 18th. Finally, JMP Securities increased their price target on shares of Sabra Health Care REIT from $21.00 to $22.00 and gave the company a “market outperform” rating in a research report on Monday, June 11th. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and five have issued a buy rating to the company. The stock presently has an average rating of “Hold” and a consensus target price of $22.73.

Several institutional investors have recently modified their holdings of the company. Tocqueville Asset Management L.P. lifted its stake in Sabra Health Care REIT by 11.9% in the second quarter. Tocqueville Asset Management L.P. now owns 21,747 shares of the real estate investment trust’s stock worth $473,000 after acquiring an additional 2,306 shares during the period. Commonwealth Equity Services LLC lifted its stake in Sabra Health Care REIT by 14.6% in the second quarter. Commonwealth Equity Services LLC now owns 19,786 shares of the real estate investment trust’s stock worth $430,000 after acquiring an additional 2,525 shares during the period. US Bancorp DE lifted its stake in Sabra Health Care REIT by 91.5% in the second quarter. US Bancorp DE now owns 5,699 shares of the real estate investment trust’s stock worth $124,000 after acquiring an additional 2,723 shares during the period. AMG Funds LLC lifted its stake in Sabra Health Care REIT by 3.8% in the first quarter. AMG Funds LLC now owns 78,475 shares of the real estate investment trust’s stock worth $1,385,000 after acquiring an additional 2,847 shares during the period. Finally, Mitsubishi UFJ Kokusai Asset Management Co. Ltd. lifted its stake in Sabra Health Care REIT by 12.0% in the first quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. now owns 28,553 shares of the real estate investment trust’s stock worth $504,000 after acquiring an additional 3,070 shares during the period. Hedge funds and other institutional investors own 90.38% of the company’s stock.

NASDAQ SBRA traded up $0.26 on Friday, reaching $23.54. 880,600 shares of the company’s stock traded hands, compared to its average volume of 1,625,028. Sabra Health Care REIT has a 12 month low of $15.77 and a 12 month high of $23.83. The company has a debt-to-equity ratio of 1.00, a current ratio of 3.16 and a quick ratio of 3.16. The stock has a market capitalization of $4.14 billion, a P/E ratio of 9.63, a PEG ratio of 2.75 and a beta of 0.63.

The company also recently announced a quarterly dividend, which was paid on Friday, August 31st. Stockholders of record on Saturday, August 18th were issued a $0.45 dividend. This represents a $1.80 annualized dividend and a dividend yield of 7.65%. The ex-dividend date of this dividend was Thursday, August 16th. Sabra Health Care REIT’s dividend payout ratio is 74.07%.

About Sabra Health Care REIT

As of June 30, 2018, Sabra's investment portfolio included 487 real estate properties held for investment (consisting of (i) 352 Skilled Nursing/Transitional Care facilities, (ii) 89 Senior Housing communities (?Senior Housing – Leased?), (iii) 24 Senior Housing communities operated by third-party property managers pursuant to property management agreements (?Senior Housing – Managed?) and (iv) 22 Specialty Hospitals and Other facilities), one asset held for sale, one investment in a direct financing lease, 22 investments in loans receivable (consisting of (i) one mortgage loan, (ii) two construction loans, (iii) one mezzanine loan, (iv) one pre-development loan and (v) 17 other loans), 13 preferred equity investments and one investment in an unconsolidated joint venture that owns 172 Senior Housing – Managed communities.

See Also: Determine Your Level of Risk Tolerance

Get a free copy of the Zacks research report on Sabra Health Care REIT (SBRA)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Sabra Health Care REIT (NASDAQ:SBRA)

Receive News & Ratings for Sabra Health Care REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Health Care REIT and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply